Speaker illustration

Miss Pei-Chen Wu

National Taiwan University, Taipei (Taiwan)

TXNDC5 is a novel therapeutic target of atrial fibrosis and fibrillation

Event: ESC Congress 2019

Topic: Arrhythmias

Session: Electrophysiology and arrhythmias

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb